Advancing pharmacy practice through research: A 2004 perspective

Journal of the American Pharmacists Association

Volumn 44, Issue 5, 2004, Pages 621-628

  Allen, Stephen J ^a   Christensen, Dale ^b   Clark, Thomas R ^c   Eckel, Fred ^b,d   Gouveia, William A ^e   Hay, Joel W ^f   Knapp, Katherine K ^g   Maine, Lucinda L ^h   McWhinney, Bruce ⁱ   Ray, Max D ^j   Schneider, Philip J ^k   Smith, William E ^l   Woodward, Billy ^m   Yanchick, Victor A ^l  

^a AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c AMERICAN SOCIETY OF CLINICAL ONCOLOGY   (United States)

^d North Carolina Association of Pharmacists   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g TOURO UNIVERSITY CALIFORNIA   (United States)

^h AMERICAN ASSOCIATION OF COLLEGES OF PHARMACY   (United States)

ⁱ CARDINAL HEALTH   (United States)

^j WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^k OHIO STATE UNIVERSITY   (United States)

^l VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^m UNIVERSITY OF TEXAS AT AUSTIN   (United States)

more..

Author keywords

Chronic disease; Collaborative practice; Medicare prescription drug benefit; Medication errors; Medication therapy management services; Pharmacy practice; Research

Indexed keywords

ARTICLE; COMMUNITY CARE; HUMAN; MEDICARE; ORGANIZATION AND MANAGEMENT; PHARMACY; RESEARCH; UNITED STATES;

COMMUNITY HEALTH SERVICES; HUMANS; MEDICARE; PHARMACY; RESEARCH; UNITED STATES;

EID: 16544383354     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.44.5.621.Allen     Document Type: Note

References (54)

1. Schumock GT, Meek PD, Ploetz PA, Vermuelen LC. Economic evaluations of clinical pharmacy services: 1988-1995. Pharmacotherapy. 1996;16:1188-208.
2. Schumock GT, Butler MG, Meek PD, et al. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy. 2003;23:113-32.
3. Pharmacy Practice Research Roundtable. Improving health care through pharmacy practice research: issues and strategies for pharmacy practice research. Dublin, Ohio: Cardinal Health; 1998:1-9.
4. Kleithermos MA. Continuity of care: the significant of the pharmacist's role. Am J Health Syst Pharm. 2003;60:1787-90.
5. Barker KN. Unit-dose injectables and the hospital medication error problem. Bull Parenter Drug Assoc. 1966;20:157-65.
6. Barker KN. The effects of an experimental medication system on medication errors and costs. I. Introduction and errors study. Am J Hosp Pharm. 1969;26:324-33.
7. Barker KN. The effects of an experimental medication system on medication errors and costs. II. The cost study. Am J Hosp Pharm. 1969;26:388-97.
8. Barker KN, Mikeal RL, Pearson RE, et al. Medication errors in nursing homes and small hospitals. Am J Hosp Pharm. 1982;39:987-91.
9. Barker KN, Pearson RE, Hepler CD, et al. Effect of an automated bedside dispensing machine on medication errors. Am J Hosp Pharm.1984;41:1352-8.
10. Cohen MR. Medication errors. Be sure insulin syringes match insulin concentration. Nursing. 1983(Nov);13:27.
11. Cohen MR. Medication errors: always prepare an I.V. admixture before labeling the container. Nursing. 1984(Mar);14:23.
12. Cohen MR. Check the doctor's order sheet before giving the first dose of a medication. Nursing. 1984(Dec);14:24.
13. Cohen MR, Davis NM. Assuring safe use of parenteral dosage forms in hospitals. Hosp Pharm. 1990(Oct);25 913-5.
14. Davis NM, Cohen MR, Teplitsky B. Look-alike and sound-alike drug names: the problem and the solution. Hosp Pharm. 1992(Feb);27:95-8,102-5,108-10.
15. McCarthy ID, Cohen MR, Kateiva J, et al. What should a pharmacy manager do when a serious medication error occurs? A panel discussion. Am J Hosp Pharm. 1992;49:1405-12.
16. Cohen MR, Davis NM. Safety alert-resolve to work on these ten drug safety issues during 1993. Hosp Pharm. 1993;28:245-7.
17. Cohen MR, Davis NM. Pharmacists must receive all incident reports involving medications. Am J Hosp Pharm. 1993;50:1575-6.
18. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events: ADE Prevention Study Group. JAMA. 1995;274:35-43.
19. Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289-97.
20. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients: Adverse Drug Event Prevention Study Group. JAMA. 1997;277:307-11.
21. Leape LL. A systems analysis approach to medical error. J Eval Clin Pract. 1997;3:213-22.
22. Anonymous. Re-engineering the medication-use system: proceedings of a national interdisciplinary conference conducted by the Joint Commission of Pharmacy Practitioners. 2000;57:537-601.
23. Committee on Quality of Health Care in America, Institute of Medicine. To err is human: building a safer health system. Kohn LT, Corrigan JM, Donaldson MS, eds. Washington D.C.: National Academy Press; 2000.
24. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington D.C.: National Academy Press. 2001.
25. Knapp KK, Ray MD. A pharmacy response to the Institute of Medicine's 2001 initiative on quality in health care. Am J Health Syst Pharm. 2002;59:2443-50.
26. Ogden JE, Muniz A, Patterson AA, et al. Pharmaceutical services in the Department of Veterans Affairs. Am J Health Syst Pharm.1997;54:761-5.
27. How does pharmacy add value? Reducing risks, improving outcomes. Pharm J. 2003;271:342-3.
28. Nelson G. Dr. Sophia Chang appointed director of chronic disease care program for CHCF. November 2003. Accessed at www.chcf.org/press/view.cfm?ItemID= 21603, November 24, 2003.
29. Aggregate Demand Index Web site. Aggregate demand index: news. September 2003. Accessed at www.pharmacymanpower.com/summary.html, November 24, 2003.
30. Health Resources & Services Administration. The pharmacist workforce: a study of the supply and demand for pharmacists. Rockville, Md.: Health Resources & Services Administration; 2000.
31. Knapp KK, Blalock SJ, Black BL. ASHP survey of ambulatory care responsibilities of pharmacists in managed care and integrated health systems-2001. Am J Health System Pharm. 2001;58:2151-66.
32. Knapp DA. Professionally determined need for pharmacy services in 2020. Am J Pharm Educ. 2002;66:421-9.
33. Punekar Y, Lin W, Thomas J III. Progress of pharmacist collaborative practice: status of state laws and regulations and perceived impact of collaborative practice. J Am Pharm Assoc. 2003;43:503-10.
34. Alliance for Pharmaceutical Care. Pharmacists for quality patient care. Washington, D.C.: Alliance for Pharmaceutical Care; 2003.
35. Pincus T, Sokka T, Stein CM. Pharmacist scope of practice. Ann Intern Med. 2002;136:79-85.
36. Rothman R, Weinberger M. The role of pharmacists in clinical care: where do we go from here? Eff Clin Pract. 2002;5:91-4.
37. How pharmacist's resistance to change affects patient care. Pharm J. 2003;271:344-5.
38. A new health system for the 21st century-crossing the quality chasm. Pharm J. 2003;271:340-1.
39. Morrison A, Wertheimer AI. Evaluation of studies investigating the effectiveness of pharmacists' clinical services. Am J Health Syst Pharm. 2001:58:569-77.
40. Singhal PK, Raisch DW, Gupchup GV. The impact of pharmaceutical services in community and ambulatory care. settings: evidence and recommendations for future research. Ann Pharmacother. 1999;33:1336-55.
41. Kennie NR, Schuster BG, Einarson TR. Critical analysis of the pharmaceutical care research literature. Ann Pharmacother. 1998;32:17-26.
42. Plumridge RJ, Wojnar-Horton RE. Review of the pharmacoeconomics of pharmaceutical care. Pharmacoeconomics.1998;14:175-89.
43. Etemad LR, Hay JW. Cost-effectiveness analysis of pharmaceutical care in a Medicare drug benefit program. Value Health. 2003;6:425-35.
44. McMullin ST, Hennenfent JA, Ritchie DJ, et al. A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions. Arch Intern Med.1999;159:2306-9.
45. Malone DC, Carter BL, Billups SJ, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000;20:149-58.
46. Yuan Y, Hay JW, McCombs JS. Effects of ambulatory-care pharmacist consultation on mortality and hospitalization. Am J Manag Care. 2003;9:45-56.
47. Benrimoj SI, Langford JH, Berry G, et al. Economic impact of increased clinical intervention rates in community pharmacy. A randomized trial of the effect of education and a professional allowance. Pharmacoeconomics. 2000;18:459-68.
48. Godley P, Nduyen A, Yokoyama K, et al. Improving hypertension care in a large group-model MCO. Am J Health Syst Pharm. 2003;60:554-64.
49. Garrett DG, Martin LA. The Asheville Project: participants' perceptions of factors contributing to the success of a patient self-management diabetes program. J Am Pharm Assoc. 2003;43:185-90.
50. Cranor CW, Christensen DB. Short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
51. Cranor CW, Christensen DB. Factors associated with outcomes among patients with diabetes enrolled in an employer-sponsored pharmaceutical care service. J Am Pharm Assoc. 2003;43:160-72.
52. Cranor CW, Bunting BA, Christensen DB. Long-term clinical and economic outcomes of the Asheville Pharmacist Diabetes Care Project. J Am Pharm Assoc. 2003;43:173-84.
53. Blendon RJ, DesRoches CM, Brodie M, et al. Patient safety: views of practicing physicians and the public on medical errors. N Engl J Med. 2002; 347:1933-40.
54. Law AV, Ray MD, Knapp KK, Balest JK. Unmet needs in the medication use process: perceptions of physicians, pharmacists, and patients. J Am Pharm Assoc. 2003;43:394-402.